Cargando…

Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes

Our aim was to demonstrate that biofilm formation in a clinical strain of methicillin-resistant Staphylococcus aureus (MRSA) can be enhanced by environment exposure in an endotracheal tube (ETT) and to determine how it is affected by systemic treatment and atmospheric conditions. Second, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Barat, Laia, Ben-Aicha, Soumaya, Motos, Anna, Vila, Jordi, Marco, Francesc, Rigol, Montserrat, Muñoz, Laura, Li Bassi, Gianluigi, Ferrer, Miquel, Torres, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085380/
https://www.ncbi.nlm.nih.gov/pubmed/30093624
http://dx.doi.org/10.1038/s41598-018-30494-7
_version_ 1783346314328670208
author Fernández-Barat, Laia
Ben-Aicha, Soumaya
Motos, Anna
Vila, Jordi
Marco, Francesc
Rigol, Montserrat
Muñoz, Laura
Li Bassi, Gianluigi
Ferrer, Miquel
Torres, Antoni
author_facet Fernández-Barat, Laia
Ben-Aicha, Soumaya
Motos, Anna
Vila, Jordi
Marco, Francesc
Rigol, Montserrat
Muñoz, Laura
Li Bassi, Gianluigi
Ferrer, Miquel
Torres, Antoni
author_sort Fernández-Barat, Laia
collection PubMed
description Our aim was to demonstrate that biofilm formation in a clinical strain of methicillin-resistant Staphylococcus aureus (MRSA) can be enhanced by environment exposure in an endotracheal tube (ETT) and to determine how it is affected by systemic treatment and atmospheric conditions. Second, we aimed to assess biofilm production dynamics after extubation. We prospectively analyzed 70 ETT samples obtained from pigs randomized to be untreated (controls, n = 20), or treated with vancomycin (n = 32) or linezolid (n = 18). A clinical MRSA strain (MRSA-in) was inoculated in pigs to create a pneumonia model, before treating with antibiotics. Tracheally intubated pigs with MRSA severe pneumonia, were mechanically ventilated for 69 ± 16 hours. All MRSA isolates retrieved from ETTs (ETT-MRSA) were tested for their in vitro biofilm production by microtiter plate assay. In vitro biofilm production of MRSA isolates was sequentially studied over the next 8 days post-extubation to assess biofilm capability dynamics over time. All experiments were performed under ambient air (O(2)) or ambient air supplemented with 5% CO(2). We collected 52 ETT-MRSA isolates (placebo N = 19, linezolid N = 11, and vancomycin N = 22) that were clonally identical to the MRSA-in. Among the ETT-MRSA isolates, biofilm production more than doubled after extubation in 40% and 50% under 5% CO(2) and O(2), respectively. Systemic antibiotic treatment during intubation did not affect this outcome. Under both atmospheric conditions, biofilm production for MRSA-in was at least doubled for 9 ETT-MRSA isolates, and assessment of these showed that biofilm production decreased progressively over a 4-day period after extubation. In conclusion, a weak biofilm producer MRSA strain significantly enhances its biofilm production within an ETT, but it is influenced by the ETT environment rather than by the systemic treatment used during intubation or by the atmospheric conditions used for bacterial growth.
format Online
Article
Text
id pubmed-6085380
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60853802018-08-16 Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes Fernández-Barat, Laia Ben-Aicha, Soumaya Motos, Anna Vila, Jordi Marco, Francesc Rigol, Montserrat Muñoz, Laura Li Bassi, Gianluigi Ferrer, Miquel Torres, Antoni Sci Rep Article Our aim was to demonstrate that biofilm formation in a clinical strain of methicillin-resistant Staphylococcus aureus (MRSA) can be enhanced by environment exposure in an endotracheal tube (ETT) and to determine how it is affected by systemic treatment and atmospheric conditions. Second, we aimed to assess biofilm production dynamics after extubation. We prospectively analyzed 70 ETT samples obtained from pigs randomized to be untreated (controls, n = 20), or treated with vancomycin (n = 32) or linezolid (n = 18). A clinical MRSA strain (MRSA-in) was inoculated in pigs to create a pneumonia model, before treating with antibiotics. Tracheally intubated pigs with MRSA severe pneumonia, were mechanically ventilated for 69 ± 16 hours. All MRSA isolates retrieved from ETTs (ETT-MRSA) were tested for their in vitro biofilm production by microtiter plate assay. In vitro biofilm production of MRSA isolates was sequentially studied over the next 8 days post-extubation to assess biofilm capability dynamics over time. All experiments were performed under ambient air (O(2)) or ambient air supplemented with 5% CO(2). We collected 52 ETT-MRSA isolates (placebo N = 19, linezolid N = 11, and vancomycin N = 22) that were clonally identical to the MRSA-in. Among the ETT-MRSA isolates, biofilm production more than doubled after extubation in 40% and 50% under 5% CO(2) and O(2), respectively. Systemic antibiotic treatment during intubation did not affect this outcome. Under both atmospheric conditions, biofilm production for MRSA-in was at least doubled for 9 ETT-MRSA isolates, and assessment of these showed that biofilm production decreased progressively over a 4-day period after extubation. In conclusion, a weak biofilm producer MRSA strain significantly enhances its biofilm production within an ETT, but it is influenced by the ETT environment rather than by the systemic treatment used during intubation or by the atmospheric conditions used for bacterial growth. Nature Publishing Group UK 2018-08-09 /pmc/articles/PMC6085380/ /pubmed/30093624 http://dx.doi.org/10.1038/s41598-018-30494-7 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Fernández-Barat, Laia
Ben-Aicha, Soumaya
Motos, Anna
Vila, Jordi
Marco, Francesc
Rigol, Montserrat
Muñoz, Laura
Li Bassi, Gianluigi
Ferrer, Miquel
Torres, Antoni
Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes
title Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes
title_full Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes
title_fullStr Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes
title_full_unstemmed Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes
title_short Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes
title_sort assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant staphylococcus aureus isolates from endotracheal tubes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085380/
https://www.ncbi.nlm.nih.gov/pubmed/30093624
http://dx.doi.org/10.1038/s41598-018-30494-7
work_keys_str_mv AT fernandezbaratlaia assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes
AT benaichasoumaya assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes
AT motosanna assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes
AT vilajordi assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes
AT marcofrancesc assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes
AT rigolmontserrat assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes
AT munozlaura assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes
AT libassigianluigi assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes
AT ferrermiquel assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes
AT torresantoni assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes